The 4th International Conference on Bioinformatics and Biomedical Engineering (iCBBE 2010) will be held from June 18th to 20th, 2010 in Chengdu, China. iCBBE 2010 will bring together top researchers from Asian Pacific areas, North America, Europe and around the world to exchange research results and address open issues in all aspects of bioinformatics and biomedical engineering.

   Harold A. Scheraga：

Professor Scheraga was trained as a physical c

我想我会一直孤单 这一辈子都这么孤单
我想我会一直孤单 这样孤单一辈子
天空越蔚蓝 越怕抬头看 电影越圆满 就越觉得伤感
有越多的时间 就越觉得不安 因为我总是孤单
过着孤单的日子 喜欢的人不出现 出现的人不喜欢
有的爱犹豫不决 还在想他就离开 想过要将就一点
却发现将就更难 于是我学着乐观 过着孤单的日子
当孤单已经变成一种习惯 习惯到我已经不再去想该怎么办
就算心烦意乱 就算没有人作伴 自由和落寞之间怎么换算
我独自走在街上看着天空 找不到答案 我没有答案
天

Chemistry:

Thomas Steitz shared the 2009 Nobel Prize in Chemistry with Venkatraman Ramakrishnan of Cambridge University and Ada E. Yonath of the Weizmann Institute of Science "for studies of the structure and function of the ribosome," one of life's core processes, the ribosome's translation of DNA information into life. They showed what the ribosome looks like and how it functions at the atomic level using a technique called X-ray crystallog

UCSF researchers have identified the two key circuits that control a cell’s ability to adapt to changes in its environment, a finding that could have applications ranging from diabetes and autoimmune research to targeted drug development for complex diseases.

The new findings are featured as the cover story in the August 21, 2009 issue of the journal “Cell” and are available online at http://www.cell.com .

博文“研究生要注意阅读本领域主流期刊的论文”（

甲: 进实验室没？ 状态可好？

乙：来所一个星期了，就一个感觉：时间太快，而自己走的太慢。感觉一天也没做啥事，时间就没了。

甲：那说明你投入了啊，别急，慢慢来。

乙：晚上躺下回想一下，脑子几乎一片空白。或许是想学的太多，自己走的太慢了吧。

甲：你或许应，该计划计划哈。

乙：对奥。必须有个计划。大的要长达到半年一学期，小的要细化到每一天，细到掌握某个技术，理解某个理论，看懂某篇paper。 时间安排好，每天必须留给自己泛读网页，精度文献基本原理，看课本做笔记自我学习的

    Although apoptosis is generally viewed as a programmed mechanism of cell suicide, necrosis has traditionally been regarded as passive cell death caused by overwhelming stress. Interestingly, although activation of death receptors by agonists such as FasL and TNFα leads to canonical apoptotic cell death in apoptotic-competent conditions, cells may undergo RIP1 kinase-dependent necrotic cell death—termed necroptosis—in apoptotic-deficient conditions. Here,

Alzheimer’s disease is the sixth leading cause of death in Nebraska, and the state has the highest rates of Parkinson’s, per resident, in the United States. Combined with the increasing number of elderly in the state, the need for improved diagnostics and targeted therapies to combat these and other deadly brain diseases is paramount.

A proposal to establish two new centers dedicated to finding new ways of treating neurodegenerative disease at UNMC was approved Friday

Researchers have found links between an individual抯 genetics and their response to treatment with chemotherapy. The findings, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues, show how a genetic variant, located in the SOD2 gene, may affect how a person responds to the chemotherapy drug cyclophosphamide. Cyclophosphamide is used in the treatment of breast and other cancers.

The SOD2 gene produces a key protein that

Snake locomotion may seem simple compared to walking or galloping. But in reality, it's no easy task to move without legs. Previous research has assumed that snakes move by pushing off of rocks and debris around them. But a study published this week in the Proceedings of the National Academy of Sciences says that it's all in their design--specifically, their scales.

New research into the treatment of Alzheimer's disease using a popular rheumatoid arthritis drug has caused some concern.

The research by the private medical group the Institute for Neurological Research in Los Angeles shows that Alzheimer's patients given the anti-inflammatory drug Enbrel (etanercept) appeared to have quite dramatic improvements in their speech.

In a small study involving 12 patients with Alzheimer's who were given the drug weekly for six months, a grea

New avatar technology combines advances in artificial intelligence and computer image rendering

Cloud computing is a hot topic in the technology world these days. Even if you're not a tech-phile, chances are if you've watched a lot of television or skimmed a business magazine, you've heard someone talking about cloud computing as the way of the future. While it's difficult to predict the future, a cloud computing infrastructure project developed at Argonne National Lab, called Nimbus, is demonstrating that cloud computing's potential is being realized now.